• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney master your money
Moneycontrol

Home » News » Buzzing Stocks

Jan 12, 2017, 09.44 AM | Source: Moneycontrol.com

Biocon at new high as USFDA accepts application for cancer drug

Biocon shares touched a record high of Rs 1,049.50 on Thursday, up nearly 5 percent intraday after the US health regulator has accepted biosimilar application for its proposed cancer drug.

Like this story, share it with millions of investors on M3

Biocon at new high as USFDA accepts application for cancer drug

Biocon shares touched a record high of Rs 1,049.50 on Thursday, up nearly 5 percent intraday after the US health regulator has accepted biosimilar application for its proposed cancer drug.

Post Your Comments

Share Cancel

Moneycontrol Bureau

Biocon shares touched a record high of Rs 1,049.50 on Thursday, up nearly 5 percent intraday after the US health regulator has accepted biosimilar application for its proposed cancer drug.

"The US Food and Drug Administration has accepted Mylan's biologics license application for MYL-14010, a proposed biosimilar Trastuzumab," the company said in its filing.

The proposed biosimilar Trastuzumab is indicated to treat certain HER2-positive breast cancers.

The company said anticipated FDA goal date set under the Biosimilar User Free Act was September 3, 2017.

"It is a major milestone for the Mylan and Biocon collaboration since it is the first US regulatory submission through their joint global biosimilars program," Arun Chandavarkar, CEO and joint MD, Biocon said.

This proposed biosimilar Trastuzumab is also under review by the European Medicines Agency.

At 09:25 hours IST, the stock was quoting at Rs 1,046.25, up Rs 45.25, or 4.52 percent on the BSE.

Posted by Sunil Shankar Matkar

Buy, Hold, Sell ? Hear it first on M3
Biocon at new high as USFDA accepts application for cancer drug

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login